Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Adrenergic receptor alpha-2 | Starlite/ChEMBL | References |
Rattus norvegicus | Adrenergic receptor alpha-1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | amine GPCR | Adrenergic receptor alpha-2 | 450 aa | 439 aa | 29.2 % |
Echinococcus multilocularis | fmrfamide receptor | Adrenergic receptor alpha-2 | 450 aa | 366 aa | 19.9 % |
Schistosoma mansoni | biogenic amine (5HT) receptor | Adrenergic receptor alpha-2 | 450 aa | 433 aa | 27.9 % |
Loa Loa (eye worm) | TYRA-2 protein | Adrenergic receptor alpha-2 | 450 aa | 488 aa | 23.8 % |
Onchocerca volvulus | Adrenergic receptor alpha-2 | 450 aa | 420 aa | 19.8 % | |
Echinococcus granulosus | alpha 1A adrenergic receptor | Adrenergic receptor alpha-2 | 450 aa | 476 aa | 21.0 % |
Echinococcus multilocularis | neuropeptides capa receptor | Adrenergic receptor alpha-2 | 450 aa | 486 aa | 20.6 % |
Onchocerca volvulus | Adrenergic receptor alpha-2 | 450 aa | 467 aa | 25.1 % | |
Echinococcus multilocularis | alpha 1A adrenergic receptor | Adrenergic receptor alpha-2 | 450 aa | 478 aa | 20.7 % |
Schistosoma japonicum | ko:K04207 neuropeptide Y receptor Y5, putative | Adrenergic receptor alpha-2 | 450 aa | 378 aa | 20.9 % |
Echinococcus granulosus | biogenic amine 5HT receptor | Adrenergic receptor alpha-2 | 450 aa | 423 aa | 31.7 % |
Echinococcus multilocularis | serotonin receptor | Adrenergic receptor alpha-2 | 450 aa | 426 aa | 31.9 % |
Schistosoma japonicum | ko:K04145 dopamine receptor D2, putative | Adrenergic receptor alpha-2 | 450 aa | 473 aa | 24.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0 | 0.5 |
Onchocerca volvulus | 0.0534 | 0 | 0.5 | |
Mycobacterium ulcerans | anthranilate phosphoribosyltransferase | 0.2124 | 0.2274 | 0.2274 |
Onchocerca volvulus | 0.0534 | 0 | 0.5 | |
Echinococcus multilocularis | thymidine phosphorylase | 0.7526 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0 | 0.5 |
Onchocerca volvulus | 0.0534 | 0 | 0.5 | |
Mycobacterium ulcerans | thymidine phosphorylase | 0.7526 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0 | 0.5 |
Schistosoma mansoni | peripheral-type benzodiazepine receptor | 0.0534 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.7526 | 1 | 1 |
Brugia malayi | TspO/MBR family protein | 0.0534 | 0 | 0.5 |
Onchocerca volvulus | 0.0534 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0 | 0.5 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.2124 | 0.2274 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 10.5 nM | Binding affinity against alpha-1 adrenergic receptor by measuring displacement of [3H]-prazosin from rat brain cortex membranes (in vitro). | ChEMBL. | 8101878 |
Ki (binding) | = 10.5 nM | Binding affinity against alpha-1 adrenergic receptor by measuring displacement of [3H]-prazosin from rat brain cortex membranes (in vitro). | ChEMBL. | 8101878 |
Ki (binding) | = 15 nM | Binding affinity against alpha-1 adrenergic receptor by measuring displacement of [3H]-prazosin from rat brain cortex membranes (in vitro). | ChEMBL. | 8101878 |
Ki (binding) | = 3334 nM | Binding affinity against alpha-2 adrenergic receptor by measuring displacement of [3H]-clonidine from rat brain cortex membranes (in vitro). | ChEMBL. | 8101878 |
Ki (binding) | = 3334 nM | Binding affinity against alpha-2 adrenergic receptor by measuring displacement of [3H]-clonidine from rat brain cortex membranes (in vitro). | ChEMBL. | 8101878 |
MBP (functional) | = -23.3 mmHg | Blood pressure lowering activity in spontaneously hypertensive rats (SHR) after 1 hour of administration(iv) of dose of 1.0 mg/kg (in vitro) | ChEMBL. | 8101878 |
MBP (functional) | = -20 mmHg | Blood pressure lowering activity in spontaneously hypertensive rats (SHR) after 6 hours of administration(iv) of dose of 1.0 mg/kg (in vitro) | ChEMBL. | 8101878 |
MBP (functional) | 0 mmHg | Blood pressure lowering activity in spontaneously hypertensive rats (SHR) after 1 hour of administration(iv) of dose of 0.5 mg/kg; Did not last more than 1/2 h (in vitro) | ChEMBL. | 8101878 |
MBP (functional) | 0 mmHg | Blood pressure lowering activity in spontaneously hypertensive rats (SHR) after 6 hours of administration(iv) of dose of 0.5 mg/kg; Did not last more than 1/2 h (in vitro) | ChEMBL. | 8101878 |
Ratio (binding) | = 1270 | Ratio of binding affinity against alpha-2 adrenoceptor to that of alpha-1 adrenoceptor | ChEMBL. | 8101878 |
Ratio (binding) | = 1270 | Ratio of binding affinity against alpha-2 adrenoceptor to that of alpha-1 adrenoceptor | ChEMBL. | 8101878 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.